Rs4149056
From SNPedia
| is a | snp |
| is | mentioned by |
| dbSNP | rs4149056 |
| hapmap | rs4149056 |
| hgdp | rs4149056 |
| ensembl | rs4149056 |
| gopubmed | rs4149056 |
| scholar | rs4149056 |
| rs4149056 | |
| pharmgkb | rs4149056 |
| hgvbaseg2p | rs4149056 |
| medrefsnp | rs4149056 |
| 23andMe | rs4149056 |
| SNP Nexus |
| Gene | SLCO1B1 |
| Chromosome | 12 |
| Orientation | plus |
| Position | 21222815 |
| Genotype | Effect |
|---|---|
| rs4149056(C;C) | reduced breakdown of some drugs; 17x increased myopathy risk for statin users |
| rs4149056(C;T) | reduced breakdown of some drugs; 5x increased myopathy risk for statin users |
| rs4149056(T;T) | normal |
| Genotypes | Magnitude | Summary |
|---|---|---|
| Rs4149056(C;C) | 33 | reduced breakdown of some drugs; 17x increased myopathy risk for statin users |
| Rs4149056(C;T) | 2.12.1 | reduced breakdown of some drugs; 5x increased myopathy risk for statin users |
| Rs4149056(T;T) | 00 | normal |
The rs4149056(C) allele gives rise to an amino acid change (from valine to alanine at residue 174) which has reduced uptake/transport activity. Therefore, drugs metabolized by OATP1B1 tend to build up to higher circulating concentrations than they would otherwise.[PMID 16758257].
The drugs known (or in some cases, thought) to be transported less well by the variant OATP1B1 protein encoded by the rs4149056(C) allele include:
- Several cholesterol lowering statins, generally leading to reduced inhibitory effects on liver cholesterol synthesis and possibly worse side effects, by such drugs as:
- fexofenadine
- repaglinide
- methotrexate
- the SN-38 active metabolite of irinotecan
- rifampicin
- caspofungin
- lopinavir
[PMID 18650507] rs4363657 in nearly complete linkage disequilibrium with rs4149056 SNP (r2=0.97), which has been linked to statin metabolism. rs4149056(C) odds ratio for myopathy among 20,000 individuals taking either 40 or 80mg of simvastatin daily was 4.5 (CI: 2.6-7.7) per copy of the C allele, and 16.9 (CI: 4.7-61.1) in (C;C) as compared with (T;T) homozygotes.
The Gene Sherpa points out a 16x odds ratio for myopathy when taking statins and suggests fenofibrates might be a good alterative.
[PMID 19833260] A study of ~500 individuals taking statins concluded that rs4149056(C), i.e. SLCO1B1*5, was associated with statin-induced side-effects, most likely somewhat correlated to the number of such alleles being carried.
spittoon discussion of this SNP
| ? | (C;C) (C;T) (T;T) |
|---|---|
|
| |
[PMID 19414484] Genome-wide association meta-analysis for total serum bilirubin levels
[PMID 19642078] Prevalence of risk factors for statin-induced myopathy in rheumatoid arthritis patients
[PMID 19901119] Germline Genetic Variation in an Organic Anion Transporter Polypeptide Associated With Methotrexate Pharmacokinetics and Clinical Effects
| PharmGKB | PA161145159 |
| Name | SLCO1B1:V174A |
| Annotation | Associated with increased pravastatin plasma AUC. |
| Gene | SLCO1B1 |
| Featue | Exon/NonSyn |
| Evidence | Web Resource:http://www.pharmgkb.org/search/annotatedGene/slco1b1/variant.jsp |
| Drugs | pravastatin |
| Diseases | |
| Curation Level | In-Depth |